Evidence map›Paper›PMID 38999117›Full record

ArticleMolecules (Basel, Switzerland)2024

Study on

Huayong Peng, Chenliang Chu, Lu Jin, Jianing Zhang, Zilei Yang, Longping Zhu, Depo Yang, Zhimin Zhao

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Oleum cinnamomi disruptsFrontiers in microbiology · 2026
    Article
  3. Molecular mechanism underlyingFrontiers in pharmacology · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Huayong PengSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 511400, China.
Chenliang ChuSchool of Food and Pharmaceutical Engineering, Zhaoqing University, Zhaoqing 526060, China.
Lu JinSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 511400, China.
Jianing ZhangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 511400, China.
Zilei YangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 511400, China.
Longping ZhuSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 511400, China.
Depo YangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 511400, China.
Zhimin ZhaoSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 511400, China.ORCID 0000-0002-3384-2365

Funding

National Key Research and Development Program of China 2022YFD1600304National Natural Science Foundation of China Youth Program 82304804Project for Provincial Agricultural Science and Technology Innovation and Promotion in Guangdong 2023KJ142Scientific and Technological Project of Yunfu 2021020605Yunnan Science and Technology Talents and Platform Program 202205AF150071
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAcroleinMetabolomicsMicrobial Sensitivity TestsPlant ExtractsPropionibacteriaceaeProteomicsAcroleinAnti-Bacterial AgentscinnamaldehydePlant ExtractsABC transporter ATP-binding proteinantibacterialcovalently modifiesCutibacterium acnesmetabolomicsNADH-quinone oxidoreductaseOleum cinnamomi

Identifiers

PMID38999117
PMCPMC11243273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.